Linux Kernel Maintainer Joins Patent Celebrations

wikinerd writes "Linux kernel maintainer Alan Cox was among those celebrating the EU decision to rethink the introduction of software patents in Europe, while Debian developer Wookey says that 'This is a very encouraging sign.' However, Alan Cox adds that 'the battle isn't over.' The EU software patent directive was criticised as anti-opensource and anti-smallbusiness, while the US patent office has granted various controversial patents like the one-click shopping."

Comments

Never truer than now

[Saven Marek]

They say "the price of freedom is eternal vigilance" and it looks like that is how europe is having to work to defeat patents.

You know well they will try again to introduce patents again and again but keep being vigilant and we will keep winning. thank you poland!!

The best mac support on the web

Hah

[mao che minh]

When politicians put things on hold to "rethink", it usally means "let's pretend we care about what the common man thinks while waiting for the corporate lobbyists to come up with more cash". I wouldn't hold my breath.

Square -1

[Doc Ruby]

Instead of repeatedly sending SW patents back to the starting point as a way of procedurally rejecting them in an endless game of snakes and ladders (chutes and ladders to Americans :), they should pass a constructive law guaranteeing freedom of innovation and expression in its place. Otherwise that IP monopoly protection racket will return every time, stronger, more wily, and attached to more attractive special cases, until it finally passes (American-style "amendments"). Europe's new leadership in true freedom must explicitly fill the power vacuum, or the revenant IP monopoly laws will.

Re:Square -1

[Doc Ruby]

I'm not so sure that patent law, at least the part that grants monopolies on inventions, is essential to medicines (pharmacological inventions). Most patented medicines, especially the most (either theraputically or profitably) successful ones, were derived directly from a traditional medicine. Asprin from the willow is the best known, but in fact most effective medicines were directly derived by researching active ingredients in aboriginally bred biology. The patents protected big corporations with global marketing from the risk of competition, but it thereby excluded competitors from using the same base from which the patenters benefitted. Including aboriginals using their own medicines, now replaced by the more expensive patented versions.

That system, perfected in the 1800s, is the model for most appropriation of public domain IP by monopolies. The latest example got a tiny bit of publicity when America revised Iraq's IP laws last year to criminalize Iraqi farmers using native seeds now available in GM form from American companies. But the entire IP protection racket is running amok. It is unjust, anticompetitive, and serves innovation only in the shortest terms, for the fewest people.